CDMO Benchmarking: Results From The 2023 CDMO Leadership Awards

The annual CDMO Leadership Awards were developed to help pharma and biopharma executives efficiently vet potential CDMO partners. Based on research from ISR Reports’ Contract Manufacturing Quality Benchmarking annual online surveys, 72 contract manufacturers were evaluated on 23 different performance metrics.

Research participants were recruited from biopharmaceutical companies of all sizes and were screened for decision-making influence and authority when it comes to working with contract manufacturing suppliers. Respondents only evaluated companies with which they have worked on an outsourced project in the past 18 months. This level of qualification ensures that quality ratings come from actual involvement with a business and that companies identified as leaders are backed by experiential data.

CDMOs have an opportunity to win these awards in up to three groups of outsourcing respondents — Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma). To see the results of 2023’s awards, click below.